SPAC23C11.07 Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Structure and Function

Antibodies (immunoglobulins) are Y-shaped glycoproteins composed of two heavy chains and two light chains. Their dual functionality is mediated by:

  • Fab Fragment: Binds antigens via paratopes (antigen-binding sites).

  • Fc Region: Engages immune effector cells (e.g., macrophages, natural killer cells) via Fc receptors and activates complement pathways .

Antibody ClassPrimary LocationKey Functions
IgGBloodstreamNeutralization, opsonization, complement activation
IgMBloodstreamComplement fixation, agglutination
IgAMucosal secretionsPathogen trapping in mucosa
IgEMast cells/basophilsAntiparasite/allergy responses

Mechanisms of Action

Antibodies neutralize pathogens through:

  • Neutralization: Blocking viral entry or toxin activity .

  • Agglutination: Clustering pathogens for phagocytosis .

  • Complement Activation: Recruiting membrane attack complexes to lyse pathogens .

  • Antibody-Dependent Cellular Cytotoxicity (ADCC): Engaging Fc receptors to trigger cytotoxicity .

Broad-Spectrum Antimicrobial Antibodies

  • 24D11 Antibody: Targets carbapenem-resistant Klebsiella pneumoniae with cross-reactivity against three capsular polysaccharide types (wzi29, wzi154, wzi50). Demonstrates complement-mediated and independent killing in human whole blood assays .

  • Abs-9 Antibody: Exhibits nanomolar affinity for Staphylococcus aureus protein A, providing prophylactic efficacy against antibiotic-resistant strains .

Cancer Immunotherapy

  • 23ME-00610 Antibody: Targets CD200R1 to enhance T-cell antitumor activity. Inhibits immunosuppressive signaling with an IC50 of 0.02 nM .

  • Urelumab: An agonist antibody to CD137, optimized at 0.1 mg/kg to minimize liver toxicity while inducing cytokine responses .

Challenges and Considerations

  • Maternal Antibodies: High concentrations in infants suppress vaccine responses, necessitating optimized immunization schedules .

  • Cross-Reactivity: SARS-CoV-2 antibodies exhibit off-target binding to human tissues (e.g., neurofilament protein, GAD-65) .

  • Fc Engineering: Glycan modifications (e.g., aglycosylation in 23ME-00610) modulate effector functions .

Research Methodologies

  • Single-Cell Sequencing: Identified potent S. aureus antibodies (Abs-9) from immunized volunteers .

  • Heterodimeric Fc Platforms: Enable dual-targeting antibodies with tailored specificity and valency .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Components: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC23C11.07 antibody; Uncharacterized protein C23C11.07 antibody
Target Names
SPAC23C11.07
Uniprot No.

Q&A

What is SPAC23C11.07 and why is it studied in Schizosaccharomyces pombe?

SPAC23C11.07 is a gene found in Schizosaccharomyces pombe (fission yeast), a model organism widely used in molecular and cellular biology research. The gene is of interest because S. pombe serves as an excellent model system for studying fundamental cellular processes due to its similarity to pathogenic fungi and its amenability to genetic analysis. The antibody against SPAC23C11.07 protein allows researchers to detect, quantify, and localize this protein in various experimental contexts, facilitating investigation of its function and regulation in cellular pathways .

What are the key specifications of the SPAC23C11.07 Antibody?

The SPAC23C11.07 Antibody (product code CSB-PA521062XA01SXV) is a polyclonal antibody raised in rabbits against recombinant Schizosaccharomyces pombe (strain 972/ATCC 24843) SPAC23C11.07 protein. It is supplied in liquid form, containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative. The antibody has been purified using antigen affinity methods and is primarily intended for research applications including ELISA and Western blotting. For optimal performance, the antibody should be stored at -20°C or -80°C, avoiding repeated freeze-thaw cycles .

How do I validate the specificity of SPAC23C11.07 Antibody in my experiments?

Validating antibody specificity is crucial for ensuring reliable research results. For SPAC23C11.07 Antibody, consider implementing the following methodological approaches:

  • Perform Western blot analysis using positive controls (wild-type S. pombe expressing SPAC23C11.07) alongside negative controls (SPAC23C11.07 deletion mutants if available)

  • Conduct immunoprecipitation followed by mass spectrometry to confirm target binding

  • Use RNA interference or CRISPR-based approaches to knock down or knock out SPAC23C11.07 expression, then validate antibody specificity by testing for reduced or absent signal

  • Cross-validate findings using orthogonal methods, such as fluorescent protein tagging of SPAC23C11.07

These validation steps help minimize the risk of experimental artifacts resulting from non-specific antibody binding .

What are the optimal conditions for using SPAC23C11.07 Antibody in Western blot applications?

For optimal Western blot results with SPAC23C11.07 Antibody, consider the following methodological guidelines:

  • Sample preparation: Extract proteins from S. pombe cells in mid-log phase using glass bead lysis in a buffer containing protease inhibitors

  • Gel electrophoresis: Separate 20-50 μg of total protein on a 10-12% SDS-PAGE gel

  • Transfer: Use PVDF membrane with standard semi-dry or wet transfer protocols

  • Blocking: Block with 5% non-fat dry milk or 3-5% BSA in TBST for 1 hour at room temperature

  • Primary antibody: Dilute SPAC23C11.07 Antibody 1:500 to 1:2000 in blocking buffer; incubate overnight at 4°C

  • Washing: Wash 3-5 times with TBST, 5-10 minutes each

  • Secondary antibody: Use anti-rabbit HRP-conjugated secondary antibody at 1:5000 to 1:10000 dilution; incubate for 1 hour at room temperature

  • Detection: Visualize using chemiluminescent substrate appropriate for the expected expression level

These conditions may require optimization depending on your specific experimental context .

How can SPAC23C11.07 Antibody be used in immunofluorescence studies?

While the product information specifically mentions ELISA and Western blot applications, researchers can adapt SPAC23C11.07 Antibody for immunofluorescence microscopy following these methodological steps:

  • Cell fixation: Fix S. pombe cells with 3.7% formaldehyde for 30 minutes, followed by cell wall digestion with zymolyase

  • Permeabilization: Treat with 0.1% Triton X-100 for 5 minutes

  • Blocking: Block with 3% BSA in PBS for 30-60 minutes

  • Primary antibody: Apply SPAC23C11.07 Antibody at 1:50 to 1:200 dilution in blocking buffer; incubate overnight at 4°C

  • Washing: Wash 3 times with PBS containing 0.1% Tween-20

  • Secondary antibody: Incubate with fluorophore-conjugated anti-rabbit antibody for 1 hour at room temperature

  • Counterstaining: Use DAPI to visualize nuclei

  • Mounting: Mount with anti-fade mounting medium

Start with a pilot experiment using different antibody dilutions to determine optimal signal-to-noise ratio for your specific application .

How can I integrate SPAC23C11.07 Antibody into systematic studies of gene function?

For comprehensive analysis of SPAC23C11.07 function, integrate antibody-based approaches with genomic and genetic techniques using this methodological framework:

  • Comparative analysis: Use SPAC23C11.07 Antibody to compare protein expression levels across various genetic backgrounds from the S. pombe deletion library (as described in search result 6)

  • Protein-protein interactions: Combine co-immunoprecipitation using SPAC23C11.07 Antibody with mass spectrometry to identify interaction partners

  • ChIP-seq applications: If SPAC23C11.07 has DNA-binding properties, adapt the antibody for chromatin immunoprecipitation followed by sequencing

  • Correlation analysis: Compare protein expression (detected by the antibody) with phenotypic data from genome-wide screens to establish functional relationships

  • Time-course experiments: Use the antibody to monitor protein expression changes in response to environmental stress or cell cycle progression

This integrated approach leverages the strengths of antibody-based detection while providing a systems-level understanding of gene function .

What strategies can I use to troubleshoot non-specific binding with SPAC23C11.07 Antibody?

When encountering non-specific binding with SPAC23C11.07 Antibody, implement this systematic troubleshooting approach:

  • Optimize antibody concentration: Test a dilution series (1:250 to 1:5000) to identify the optimal concentration that maximizes specific signal while minimizing background

  • Modify blocking conditions: Try alternative blocking agents (e.g., fish gelatin, casein) or increase blocking time/concentration

  • Adjust washing stringency: Increase wash buffer salt concentration (up to 500 mM NaCl) or add 0.1-0.5% SDS to reduce non-specific interactions

  • Perform pre-adsorption: Incubate antibody with cellular extracts from SPAC23C11.07 deletion strains to pre-adsorb antibodies that recognize non-specific epitopes

  • Use alternative detection methods: Compare chemiluminescence, fluorescence, and colorimetric detection to identify the method with optimal signal-to-noise ratio

  • Consider antibody purification: Perform additional affinity purification against the specific antigen

Document all optimization steps to establish a reliable protocol for future experiments .

How can I apply machine learning approaches to analyze data generated using SPAC23C11.07 Antibody?

Machine learning techniques can enhance the analysis of data generated using SPAC23C11.07 Antibody through the following methodological framework:

  • Image analysis automation: Train convolutional neural networks to automatically identify and quantify immunofluorescence signals from SPAC23C11.07 Antibody staining

  • Pattern recognition: Apply unsupervised learning algorithms to identify patterns in protein expression across different experimental conditions

  • Multi-omics data integration: Combine antibody-derived protein expression data with transcriptomics, proteomics, and phenomics data using deep learning models

  • Predictive modeling: Develop models that predict cellular responses based on SPAC23C11.07 expression patterns

  • Feature importance analysis: Identify which experimental variables most strongly influence SPAC23C11.07 protein expression or localization

This approach parallels methods described for antibody sequence analysis in research using statistical testing and machine learning techniques such as those in the ASAP-SML pipeline .

What are the best practices for storing and handling SPAC23C11.07 Antibody to maintain activity?

To maximize the shelf life and activity of SPAC23C11.07 Antibody, implement these storage and handling protocols:

  • Long-term storage: Store at -80°C in single-use aliquots (10-50 μL) to minimize freeze-thaw cycles

  • Working stock: Maintain a small working aliquot at -20°C for routine experiments

  • Thawing procedure: Thaw antibody gradually on ice rather than at room temperature

  • Handling: Avoid vortexing; instead, mix by gentle inversion or flicking

  • Temperature control: Keep on ice during experiment preparation

  • Contamination prevention: Use sterile pipette tips and tubes when handling the antibody

  • Stabilizers: The antibody is provided in 50% glycerol buffer with preservative; do not dilute stock solution unless for immediate use

  • Record keeping: Maintain a log of freeze-thaw cycles and dates of use to track potential degradation

With proper handling, the antibody should maintain activity within specifications for at least 12 months from receipt .

How can I quantitatively compare SPAC23C11.07 protein levels across different experimental conditions?

For rigorous quantitative comparison of SPAC23C11.07 protein levels, implement this standardized workflow:

  • Sample normalization: Ensure equal total protein loading (20-50 μg) across all samples, confirmed by staining with total protein stains (e.g., Ponceau S)

  • Internal controls: Include invariant reference proteins (e.g., GAPDH, actin) on each blot

  • Technical replication: Perform at least three technical replicates for each biological condition

  • Standard curve: Include a dilution series of a reference sample to confirm linearity of detection

  • Digital quantification: Use software like ImageJ to perform densitometry analysis

  • Normalization strategy: Express SPAC23C11.07 levels relative to total protein or reference proteins

  • Statistical analysis: Apply appropriate statistical tests (e.g., t-test, ANOVA) with corrections for multiple comparisons

This approach ensures reproducible and statistically sound comparisons of protein expression across experimental conditions .

How can SPAC23C11.07 Antibody be used in undergraduate teaching laboratories?

SPAC23C11.07 Antibody can be integrated into undergraduate immunology and molecular biology teaching laboratories through this structured approach:

  • Practical workflow design: Create a 7-week laboratory project similar to the hybridoma-based curriculum described in search result 2, where students:

    • Culture S. pombe cells under different conditions

    • Extract proteins and quantify total protein concentration

    • Perform Western blot analysis using SPAC23C11.07 Antibody

    • Analyze and interpret results in the context of experimental variables

  • Experimental design skills: Allow students to modify growth conditions and monitor effects on SPAC23C11.07 protein expression, requiring them to:

    • Develop hypotheses about protein function based on literature

    • Design appropriate controls

    • Select relevant experimental variables

    • Present findings in poster format

  • Technical skill development: Students learn fundamental techniques including:

    • Cell culture maintenance

    • Protein extraction and quantification

    • SDS-PAGE and Western blotting

    • Antibody dilution and incubation optimization

    • Data analysis and interpretation

This approach provides students with authentic research experiences while teaching core concepts in protein analysis and antibody techniques .

How can I analyze the evolutionary conservation of the SPAC23C11.07 protein using antibody cross-reactivity?

To investigate evolutionary conservation of SPAC23C11.07 protein across fungal species, employ this methodological approach:

  • Cross-reactivity testing: Test SPAC23C11.07 Antibody against protein extracts from:

    • Multiple S. pombe strains

    • Related Schizosaccharomyces species (S. japonicus, S. octosporus)

    • More distant fungi (Saccharomyces cerevisiae, Candida albicans)

    • Pathogenic fungi of interest

  • Epitope mapping: Identify the specific epitopes recognized by the antibody through:

    • Peptide array analysis

    • Truncation mutant testing

    • Comparative sequence analysis

  • Structural analysis: If cross-reactivity is observed, use computational methods to:

    • Align sequences of homologous proteins

    • Predict conserved structural features

    • Model three-dimensional structures of homologs

  • Functional conservation: Compare protein function across species through:

    • Complementation studies in deletion mutants

    • Expression of tagged homologs in S. pombe

This approach leverages antibody cross-reactivity as a tool for evolutionary and comparative studies across fungal species .

What statistical approaches are recommended for analyzing Western blot data generated with SPAC23C11.07 Antibody?

For robust statistical analysis of Western blot data using SPAC23C11.07 Antibody, implement this analytical framework:

  • Experimental design considerations:

    • Perform at least three biological replicates

    • Include technical replicates within each biological replicate

    • Incorporate appropriate positive and negative controls

  • Quantification methodology:

    • Use densitometry software (ImageJ, Image Lab) for band intensity measurement

    • Subtract local background from each band

    • Normalize to loading controls or total protein stain

  • Statistical analysis workflow:

    • Test for normality using Shapiro-Wilk or Kolmogorov-Smirnov tests

    • For normally distributed data: Apply parametric tests (t-test, ANOVA)

    • For non-normally distributed data: Use non-parametric alternatives (Mann-Whitney, Kruskal-Wallis)

    • Apply multiple comparison corrections (Bonferroni, Benjamini-Hochberg) when appropriate

  • Data visualization:

    • Present data as mean ± standard deviation or standard error

    • Use box plots or violin plots to show data distribution

    • Include individual data points for transparency

  • Reporting standards:

    • Document all normalization procedures

    • Report exact p-values rather than significance thresholds

    • Provide sample sizes for all experimental groups

This approach ensures scientifically sound interpretation of quantitative data derived from Western blot experiments .

How can I integrate findings from SPAC23C11.07 Antibody studies with public datasets?

To maximize the research value of SPAC23C11.07 Antibody studies through integration with public datasets, follow this methodological framework:

  • Transcriptomic correlation analysis:

    • Compare protein expression data (from Western blots) with RNA-seq datasets from the same conditions

    • Calculate protein-mRNA correlation coefficients to identify potential post-transcriptional regulation

  • Proteomic data integration:

    • Cross-reference your SPAC23C11.07 abundance measurements with public proteomics datasets

    • Identify proteins with similar expression patterns through clustering analysis

  • Genetic interaction mapping:

    • Correlate SPAC23C11.07 protein levels with phenotypic data from genome-wide deletion screens

    • Generate hypothesis about functional relationships

  • Phylogenetic profiling:

    • Compare presence/absence and conservation of SPAC23C11.07 across fungal species

    • Identify co-evolved gene sets that may function in the same pathway

  • Structure-function analysis:

    • Use antibody epitope information alongside protein structure databases

    • Identify functional domains and potential regulatory regions

This integrative approach contextualizes experimental findings within the broader research landscape, enhancing their interpretability and impact .

What emerging technologies might enhance SPAC23C11.07 Antibody applications in fungal research?

Several emerging technologies have the potential to significantly expand SPAC23C11.07 Antibody applications in fungal research:

  • Proximity labeling approaches:

    • Adapt SPAC23C11.07 Antibody for BioID or APEX2 proximity labeling

    • Identify proteins physically close to SPAC23C11.07 in living cells

  • Super-resolution microscopy:

    • Employ techniques like STORM or PALM with fluorophore-conjugated antibodies

    • Achieve nanometer-scale resolution of protein localization

  • Single-cell proteomics integration:

    • Combine antibody-based detection with microfluidic single-cell isolation

    • Analyze cell-to-cell variation in protein expression

  • Deep learning image analysis:

    • Develop neural networks trained to recognize subcellular patterns in immunofluorescence

    • Automate quantification of protein dynamics across large datasets

  • Multimodal data analysis platforms:

    • Create integrated workflows that combine antibody-derived data with genomics, transcriptomics, and metabolomics

    • Apply machine learning to identify emergent patterns across multiple data types

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.